The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

Hyperamylasemia in Diabetic Ketoacidosis: Sources and Significance

[+] Article, Author, and Disclosure Information

Grant support: in part by Indiana University Diabetes Research and Training Center (PHS-P60-AM-20542-01), Indiana University Human Genetics Center (PHS-50-GM-21054), Regenstrief Institute, and the National Institutes of Health (Research Grant PHS-R01-GM-19178). Dr. Vinicor was a Research Associate, Veterans Administration Hospital (MRIS #9035); Dr. Karn was supported by a Career Development Award (1-K04-AM-00284-01).

Portions of this paper have appeared in abstract form: Diabetes. 1978;27(suppl 2):319.

▸Requests for reprints should be addressed to Frank Vinicor, M.D.; Regenstrief Institute-Indiana University School of Medicine, 1100 West Michigan Street; Indianapolis, IN 46223.

Indianapolis, Indiana

© 1979 American College of PhysiciansAmerican College of Physicians

Ann Intern Med. 1979;91(2):200-204. doi:10.7326/0003-4819-91-2-200
Text Size: A A A

The origins and clinical significance of hyperamylasemia during diabetic ketoacidosis are unclear. We have therefore correlated important clinical and laboratory indices of diabetic ketoacidosis with sequential determinations of serum and urine amylase concentrations, amylase/creatinine clearance ratios, and specific amylase isozyme types. Hyperamylasemia occurred in 79% of our patients with diabetic ketoacidosis, often after admission to the hospital. Among these patients, 48% had pancreatic-type, 36% salivary-type, and 16% mixed-type (pancreatic and salivary) hyperamylasemia. There were no correlations between the presence, degree, or isozyme type of hyperamylasemia and most laboratory or clinical characteristics, including gastrointestinal symptoms. Patients with pancreatic-type hyperamylasemia tended to have higher amylase/creatinine clearance ratios, but it was not possible to unequivocably diagnose acute pancreatitis during diabetic ketoacidosis with current routine clinical or laboratory procedures.





Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $42.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Journal Club
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.